Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastro Intestinal Stromal Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07109024
What this trial is testing

Resistance Profiling Using Functional Imaging and Next Generation Sequencing in Refractory Gastrointestinal Stomal Tumors (GIST)

Who this might be right for
Gastrointestinal Stromal Tumor (GIST)
Universität Duisburg-Essen 40
Testing effectiveness (Phase 2)UnknownNCT01389583
What this trial is testing

AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients

Who this might be right for
Gastrointestinal Stromal Tumor
National Health Research Institutes, Taiwan 25
Testing effectiveness (Phase 2)Study completedNCT00112632
What this trial is testing

Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor

Who this might be right for
Gastrointestinal Stromal Tumor
Technical University of Munich 40
Testing effectiveness (Phase 2)WithdrawnNCT01270893
What this trial is testing

Tasigna Neoadjuvant Gastrointestinal Stromal Tumor (GIST)

Who this might be right for
Gastrointestinal Cancer
M.D. Anderson Cancer Center
Post-approval studies (Phase 4)UnknownNCT00777504
What this trial is testing

Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors

Who this might be right for
Renal Cell CarcinomaGastrointestinal Stromal Tumor
Radboud University Medical Center 30
Early research (Phase 1)Study completedNCT00005858
What this trial is testing

LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+3 more
University of Maryland, Baltimore 25
Large-scale testing (Phase 3)UnknownNCT00685828
What this trial is testing

Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor

Who this might be right for
Gastrointestinal Stromal Tumor
European Organisation for Research and Treatment of Cancer - EORTC 946
Testing effectiveness (Phase 2)Study completedNCT02257541
What this trial is testing

BGJ398 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)

Who this might be right for
Advanced Gastrointestinal Stromal Tumor (GIST)
Memorial Sloan Kettering Cancer Center 16
Early research (Phase 1)Looking for participantsNCT07618377
What this trial is testing

Study of DCC-2618 in Patients With GIST After at Least 3 Prior Treatments

Who this might be right for
Gastrointestinal Stromal Tumors
Ono Pharmaceutical Co., Ltd. 10
Early research (Phase 1)Study completedNCT02574663
What this trial is testing

TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors

Who this might be right for
Pancreatic CancerColorectal CancerRectal Cancer+3 more
TG Therapeutics, Inc. 66
Large-scale testing (Phase 3)Ended earlyNCT00009906
What this trial is testing

Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor

Who this might be right for
Gastrointestinal Stromal Tumor
National Cancer Institute (NCI) 748
Testing effectiveness (Phase 2)Looking for participantsNCT07406633
What this trial is testing

KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)

Who this might be right for
GIST - Gastrointestinal Stromal TumorGISTGIST Metastatic Cancer+2 more
Kumquat Biosciences Inc. 46
Testing effectiveness (Phase 2)Study completedNCT03440515
What this trial is testing

Management of Imatinib-associated Severe Skin Rash in Patients With Gastrointestinal Stromal Tumor

Who this might be right for
Gastrointestinal Stromal Tumor(GIST)
Asan Medical Center 29
Not applicableStudy completedNCT06038552
What this trial is testing

Comparison of Clinical Efficacy of Liver Resection, RFA, TACE, and Drug Therapy in Patients with GIST LM

Who this might be right for
GIST, MalignantLiver Metastases
First Affiliated Hospital, Sun Yat-Sen University 238
Post-approval studies (Phase 4)UnknownNCT00274885
What this trial is testing

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Who this might be right for
Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 58
Not applicableUnknownNCT04344847
What this trial is testing

Incidental Finding of Gastrointestinal Stromal Tumors (GISTs) During Laparoscopic Sleeve Gastrectomy, How to Deal? How Much Safety Margin

Who this might be right for
Excision Margin
Bassem Mohamed Sieda 338
Early research (Phase 1)Study completedNCT00055705
What this trial is testing

PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Looking for participantsNCT03594422
What this trial is testing

HQP1351 in Patients With GIST or Other Solid Tumors

Who this might be right for
Gastrointestinal Stromal Tumor (GIST)Solid Tumor, Adult
Ascentage Pharma Group Inc. 100
Large-scale testing (Phase 3)Study completedNCT00367861
What this trial is testing

Prospective Multicentric Randomized Study of Glivec® in Advanced GIST Expressing C-kit: Interruption After 5 Years vs Maintenance

Who this might be right for
SarcomaGastro-intestinal Stromal Tumors (GIST)
Centre Leon Berard 564
Early research (Phase 1)Temporarily pausedNCT04714983
What this trial is testing

DNX-2440 for Resectable Colorectal Liver Metastasis

Who this might be right for
Liver MetastasesLiver Metastasis Colon CancerColorectal Cancer+8 more
DNAtrix, Inc. 30
Next Page